Trademark: 97239667
Status Date
Monday, January 22, 2024
Filing Date
Wednesday, January 26, 2022
Published for Opposition
Tuesday, October 25, 2022
Abandoned Date
Monday, January 22, 2024
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Jan 22, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 22, 2024
Abandonment - No Use Statement Filed
Dec 20, 2023
Assignment Of Ownership Not Updated Automatically
Dec 19, 2023
Teas Change Of Correspondence Received
Dec 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 19, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 19, 2023
Teas Change Of Owner Address Received
Jun 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 12, 2023
Sou Extension 1 Granted
Jun 12, 2023
Sou Extension 1 Filed
Jun 12, 2023
Sou Teas Extension Received
Dec 20, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 16, 2022
Approved For Pub - Principal Register
Sep 15, 2022
Assigned To Examiner
Jan 31, 2022
New Application Office Supplied Data Entered
Jan 29, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
